| Authors: |
Ratziu V; Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié Salpêtrière, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France., Francque S; Antwerp University Hospital, Antwerp, Belgium.; InflaMed Centre of Excellence, Laboratory for Experimental Medicine and Paediatrics, Translational Sciences in Inflammation and Immunology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Antwerp, Belgium., Behling CA; Pacific Rim Pathology, San Diego, California, USA., Cejvanovic V; Novo Nordisk A/S, Søborg, Denmark., Cortez-Pinto H; Clínica Universitária de Gastrenterologia, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Iyer JS; PathAI Inc., Boston, Massachusetts, USA., Krarup N; Novo Nordisk A/S, Søborg, Denmark., Le Q; PathAI Inc., Boston, Massachusetts, USA., Sejling AS; Novo Nordisk A/S, Søborg, Denmark., Tiniakos D; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Department of Pathology, Aretaieion Hospital, National and Kapodistrian University of Athens, Athens, Greece., Harrison SA; Radcliffe Department of Medicine, University of Oxford, Oxford, UK. |